Cartesian Therapeutics Files S-8 for Employee Stock Plans
Ticker: RNAC · Form: S-8 · Filed: Apr 30, 2026 · CIK: 0001453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | S-8 |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: employee-benefit-plan, stock-registration, sec-filing
TL;DR
Cartesian Therapeutics just filed an S-8 for employee stock plans, effective 4/30/26.
AI Summary
Cartesian Therapeutics, Inc. filed an S-8 form on April 30, 2026, to register an unspecified number of securities to be offered under its employee benefit plans. This filing indicates the company is making shares available for its employees, likely as part of compensation or incentive programs. The effectiveness date for this registration is also April 30, 2026.
Why It Matters
This filing allows Cartesian Therapeutics to issue stock to employees, which can be a key tool for attracting and retaining talent in the competitive biotech sector.
Risk Assessment
Risk Level: low — An S-8 filing is a routine registration of securities for employee benefit plans and does not inherently represent new financial risk or significant operational changes.
Key Numbers
- 2026-04-30 — Filing and Effectiveness Date (Indicates when the securities registration became active.)
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Filer of the S-8 form
- 0001453687 (company) — CIK number for Cartesian Therapeutics, Inc.
- 2026-04-30 (date) — Filing date and effectiveness date of the S-8 form
- 333-295424 (dollar_amount) — File number associated with the S-8 registration
FAQ
What type of securities are being registered under the S-8 form?
The S-8 form registers securities to be offered to employees in employee benefit plans, but the specific type and number of shares are not detailed in the provided filing summary.
What is the purpose of an S-8 filing?
An S-8 filing is used by companies to register securities that will be offered to employees under an employee benefit plan, such as stock options or restricted stock units.
When did Cartesian Therapeutics file this S-8 form?
Cartesian Therapeutics filed the S-8 form on April 30, 2026.
What is the effectiveness date of this S-8 filing?
The effectiveness date for this S-8 filing is April 30, 2026.
Where is Cartesian Therapeutics, Inc. located?
Cartesian Therapeutics, Inc. has its mailing and business address at 7495 NEW HORIZON WAY, FREDERICK MD 21703.
Filing Details
This Form S-8 (Form S-8) was filed with the SEC on April 30, 2026 regarding Cartesian Therapeutics, Inc. (RNAC).